Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer

Homologous recombination (HR) is a DNA repair pathway that is deficient in 50% of high-grade serous ovarian carcinomas (HGSOC). Deficient HR (DHR) constitutes a therapeutic opportunity for these patients, thanks to poly (ADP-ribose) polymerases (PARP) inhibitors (PARPi; olaparib, niraparib, and ruca...

Descripción completa

Detalles Bibliográficos
Autores principales: Romeo, Margarita, Pardo, Juan Carlos, Martínez-Cardús, Anna, Martínez-Balibrea, Eva, Quiroga, Vanesa, Martínez-Román, Sergio, Solé, Francesc, Margelí, Mireia, Mesía, Ricard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214122/
https://www.ncbi.nlm.nih.gov/pubmed/30347758
http://dx.doi.org/10.3390/ijms19103249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214122/
https://www.ncbi.nlm.nih.gov/pubmed/30347758
http://dx.doi.org/10.3390/ijms19103249

Ejemplares similares